Sernova Biotherapeutics (SEOVF) Expected to Post Quarterly Earnings on Thursday

Sernova Biotherapeutics (OTCMKTS:SEOVF) will likely be announcing its resultson Thursday, September 10th. Analysts expect the company to post earnings of ($0.0029) per share for the quarter.

Sernova Biotherapeutics (OTCMKTS:SEOVF) last released its earnings results on Thursday, June 11th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01).

Sernova Biotherapeutics Stock Up 21.8%

Shares of SEOVF opened at $0.10 on Wednesday. The stock has a market cap of $37.35 million, a P/E ratio of -2.47 and a beta of 0.86. The business’s 50 day moving average price is $0.08 and its 200-day moving average price is $0.10. Sernova Biotherapeutics has a 52 week low of $0.07 and a 52 week high of $0.15.

About Sernova Biotherapeutics

Sernova Biotherapeutics is a clinical?stage biotechnology company focused on developing and commercializing cell?based therapeutic technologies for patients with chronic and life?threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.